Arkolith/Insider Trading/MAZE/Form 4

Coloma Jason V

Chief Executive Officer, DirectorMaze Therapeutics, Inc. (MAZE) · full profile →Form 4 · filed May 18, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$50K
Net Open-Market Flow
-$50K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 15, 2026Sell(S)2K$26.00$47K381K
May 15, 2026Sell(S)116$26.00$3K31K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001676170-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML